UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010589
Receipt number R000012330
Scientific Title A phase II study of TEGAFOX as adjuvant therapy for elderly patients with stage III and stage II colorectal cancer with risk factors for recurrence.
Date of disclosure of the study information 2013/04/30
Last modified on 2019/10/29 09:18:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase II study of TEGAFOX as adjuvant therapy for elderly patients with stage III and stage II colorectal cancer with risk factors for recurrence.

Acronym

A phase II study of TEGAFOX as adjuvant therapy for with stage III and stage II colorectal cancer with risk factors for recurrence.

Scientific Title

A phase II study of TEGAFOX as adjuvant therapy for elderly patients with stage III and stage II colorectal cancer with risk factors for recurrence.

Scientific Title:Acronym

A phase II study of TEGAFOX as adjuvant therapy for with stage III and stage II colorectal cancer with risk factors for recurrence.

Region

Japan


Condition

Condition

colon cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the feasibility of the TEGAFOX followed by UFT/LV for patients with stage III and stage II colon cancer with risk factors of recurrence.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

feasibility

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

UFT 300mg per m2 per day and LV 75mg per day for 28 days
Oxaliplatin:85mg/m2 day1,15
every 5-weeks for 3-cycle
After this therapy, followed by UFT/LV
2-cycle

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

70 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)with histologically confirmed colorectal cancer

2)with histologically confirmed stageIII and stageII colorectal cancer stageII:has at least one of the following factors
-ileus
-vascular invasion-positive
-T4
-poorly differentiated adenocarcinoma or undifferentiated carcinoma
-perforaiton
-lymph node dissection:less than 12

3)>=D2 lymph node dissection
4)Pathological curability is A or B
5)is aged 70 and over
6)Performance status 0-1
7)Without prior anti-tumor therapy
8)Adequate organ function
9)can start the therapy within 8weeks after surgery.
10)can take drugs orally.
11)whose written consent is taken.

Key exclusion criteria

1)Multiple malignancies within five
years
2) Other severe complications, such as
pulmonary emphysema, pulmonary fibrosis, hyper pulmonary
emphysema,paralysis intestinal,
intestinal obstruction, uncontrollable diabetes, cirrhosis, uncontrollable
hypertension, myocardial infarction
within six months, angina.
3)has severe diarrhea
4)with psychosis or psychoneyrosis
5) In case that the doctor judged that he/she is disqualified for the enrollment in this clinical trial.

Target sample size

75


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kimihiko Funahashi

Organization

Toho University Medical Center Omori hospital

Division name

Depaetment of Gastoroenterological Surgery

Zip code


Address

6-11-1, Omori-nishi Ota-ku, Tokyo, Japan

TEL

03-3762-4151

Email

kingkong@med.toho-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kimihiko Funahashi

Organization

Toho University Medical Center Omori hospital

Division name

Depaetment of Gastoroenterological Surgery

Zip code


Address

6-11-1, Omori-nishi Ota-ku, Tokyo, Japan

TEL

03-3762-4151

Homepage URL


Email

kingkong@med.toho-u.ac.jp


Sponsor or person

Institute

Toho University Medical Center Omori hospital

Institute

Department

Personal name



Funding Source

Organization

Toho University Medical Center Omori hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 04 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 02 Month 13 Day

Date of IRB

2015 Year 06 Month 03 Day

Anticipated trial start date

2013 Year 04 Month 12 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 04 Month 24 Day

Last modified on

2019 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012330


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name